Nifty
Sensex
:
:
11834.30
40317.81
66.55 (0.57%)
172.31 (0.43%)

Pharmaceuticals & Drugs - Domestic

Rating :
73/99  (View)

BSE: 531599 | NSE: FDC

340.75
-4.20 (-1.22%)
27-Oct-2020 | 11:59AM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  343.20
  •  346.70
  •  340.05
  •  344.95
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  39223
  •  133.65
  •  379.00
  •  166.55

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 5,898.57
  • 21.42
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 5,872.04
  • 0.23%
  • 3.60

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 69.24%
  • 0.77%
  • 14.63%
  • FII
  • DII
  • Others
  • 6.72%
  • 3.46%
  • 5.18%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.57
  • 6.22
  • 7.73

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 5.85
  • 5.07
  • 5.26

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 4.79
  • 7.33
  • 11.45

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 19.50
  • 20.73
  • 19.71

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.95
  • 3.05
  • 2.82

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 11.79
  • 13.04
  • 12.67

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Net Sales
308
344
-10%
333
271
23%
321
256
25%
346
274
26%
Expenses
205
265
-23%
304
228
34%
236
200
18%
272
216
26%
EBITDA
104
78
32%
29
43
-32%
85
56
50%
74
57
29%
EBIDTM
34%
23%
14%
16%
26%
22%
21%
21%
Other Income
28
10
186%
38
14
171%
31
14
122%
17
9
94%
Interest
1
1
-7%
1
0
175%
1
0
126%
1
0
156%
Depreciation
9
9
1%
9
8
18%
9
8
23%
10
9
6%
PBT
121
78
55%
57
48
19%
106
63
69%
80
57
42%
Tax
29
22
35%
1
11
-92%
32
17
91%
26
16
58%
PAT
92
56
63%
56
36
54%
74
46
61%
54
40
35%
PATM
30%
16%
7%
13%
23%
18%
16%
15%
EPS
5.38
3.30
63%
3.27
2.13
54%
4.34
2.69
61%
3.18
2.35
35%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
1,309
1,344
1,091
1,075
1,014
994
889
846
773
711
712
Net Sales Growth
14%
23%
1%
6%
2%
12%
5%
9%
9%
0%
 
Cost Of Goods Sold
4,937
426
345
352
339
358
273
266
311
238
254
Gross Profit
-3,628
918
746
723
675
636
616
580
462
473
458
GP Margin
-277%
68%
68%
67%
67%
64%
69%
69%
60%
67%
64%
Total Expenditure
1,017
1,051
860
848
770
766
691
641
592
547
546
Power & Fuel Cost
-
27
25
22
22
23
20
18
17
14
13
% Of Sales
-
2%
2%
2%
2%
2%
2%
2%
2%
2%
2%
Employee Cost
-
277
226
217
191
176
138
122
108
99
86
% Of Sales
-
21%
21%
20%
19%
18%
15%
14%
14%
14%
12%
Manufacturing Exp.
-
61
62
59
49
36
97
89
23
70
67
% Of Sales
-
5%
6%
5%
5%
4%
11%
10%
3%
10%
9%
General & Admin Exp.
-
58
59
62
53
50
41
36
34
34
32
% Of Sales
-
4%
5%
6%
5%
5%
5%
4%
4%
5%
4%
Selling & Distn. Exp.
-
95
79
76
64
58
65
58
56
55
55
% Of Sales
-
7%
7%
7%
6%
6%
7%
7%
7%
8%
8%
Miscellaneous Exp.
-
107
64
61
52
65
56
52
43
37
55
% Of Sales
-
8%
6%
6%
5%
6%
6%
6%
6%
5%
6%
EBITDA
292
293
231
227
243
229
199
204
181
163
166
EBITDA Margin
22%
22%
21%
21%
24%
23%
22%
24%
23%
23%
23%
Other Income
114
69
43
51
50
39
46
42
46
29
28
Interest
3
3
1
1
1
1
2
3
2
1
1
Depreciation
38
37
33
35
35
34
39
25
28
18
17
PBT
364
321
240
241
258
233
204
218
198
172
175
Tax
88
80
67
67
63
63
56
83
43
38
24
Tax Rate
24%
25%
28%
28%
25%
27%
27%
38%
22%
22%
14%
PAT
276
241
172
174
188
169
148
135
155
134
151
PAT before Minority Interest
276
241
172
174
188
169
148
135
155
134
151
Minority Interest
0
0
0
0
0
0
0
0
0
0
0
PAT Margin
21%
18%
16%
16%
19%
17%
17%
16%
20%
19%
21%
PAT Growth
54%
40%
-1%
-8%
11%
14%
9%
-13%
16%
-11%
 
EPS
16.17
14.09
10.05
10.17
11.02
9.89
8.66
7.91
9.07
7.84
8.82

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
1,547
1,445
1,276
1,270
1,082
936
845
784
695
616
Share Capital
17
18
18
18
18
18
18
18
18
19
Total Reserves
1,530
1,428
1,259
1,252
1,065
919
827
766
677
598
Non-Current Liabilities
315
229
211
217
20
24
31
31
30
30
Secured Loans
0
0
0
0
0
0
0
0
1
1
Unsecured Loans
0
0
1
1
1
1
1
1
1
2
Long Term Provisions
296
214
194
199
0
1
0
0
0
2
Current Liabilities
565
497
480
389
163
188
196
154
139
123
Trade Payables
118
78
97
75
83
87
80
61
58
46
Other Current Liabilities
80
62
69
64
50
37
43
36
30
30
Short Term Borrowings
0
0
0
0
0
1
1
1
1
1
Short Term Provisions
367
358
314
250
31
63
72
56
50
47
Total Liabilities
2,427
2,172
1,968
1,876
1,266
1,148
1,072
970
865
769
Net Block
674
682
674
678
675
393
284
289
293
277
Gross Block
845
818
776
746
709
630
470
453
430
396
Accumulated Depreciation
171
136
103
68
34
237
186
164
137
119
Non Current Assets
1,181
1,113
977
958
742
646
619
558
418
322
Capital Work in Progress
24
12
13
6
20
29
18
7
11
10
Non Current Investment
162
179
74
54
39
217
187
245
96
14
Long Term Loans & Adv.
321
239
215
218
8
6
129
15
17
19
Other Non Current Assets
1
1
1
1
0
1
1
2
1
2
Current Assets
1,245
1,058
991
918
523
502
452
411
446
447
Current Investments
502
406
397
437
285
272
230
171
244
249
Inventories
210
174
160
137
131
123
103
100
103
97
Sundry Debtors
124
88
82
76
62
61
59
43
42
41
Cash & Bank
32
21
29
28
18
15
23
36
17
18
Other Current Assets
377
11
11
10
27
30
36
60
41
42
Short Term Loans & Adv.
350
359
312
230
20
15
28
49
35
40
Net Current Assets
681
561
511
529
360
314
256
257
307
323
Total Assets
2,427
2,172
1,968
1,876
1,266
1,148
1,072
970
865
769

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
250
112
150
154
174
128
150
150
144
121
PBT
320
238
241
258
232
204
218
198
172
175
Adjustment
23
0
0
-11
2
-1
-8
-14
-3
1
Changes in Working Capital
-8
-51
-23
-19
-5
-12
7
4
9
-21
Cash after chg. in Working capital
335
186
218
228
230
190
218
188
179
156
Interest Paid
0
0
0
0
0
0
0
0
0
0
Tax Paid
-84
-74
-68
-70
-56
-63
-68
-38
-34
-35
Other Direct Exp. Paid
0
0
0
0
0
0
0
0
0
0
Extra & Other Items
0
0
0
-3
0
0
0
0
0
0
Cash From Investing Activity
-98
-120
20
-144
-73
-89
-55
-107
-108
-33
Net Fixed Assets
-39
-41
-37
-24
-82
-170
-28
-20
-26
-18
Net Investments
-80
-114
20
-166
170
-72
-1
-76
-83
-34
Others
20
34
37
47
-162
154
-26
-12
1
18
Cash from Financing Activity
-142
0
-169
0
-97
-48
-75
-63
-58
-58
Net Cash Inflow / Outflow
10
-8
1
11
4
-9
19
-20
-22
30
Opening Cash & Equivalents
20
28
27
16
12
23
4
24
46
16
Closing Cash & Equivalent
30
20
28
27
16
15
23
4
24
46

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
91
83
73
71
61
53
47
43
38
33
ROA
10%
8%
9%
12%
14%
13%
13%
17%
16%
21%
ROE
16%
13%
14%
16%
17%
17%
17%
21%
20%
26%
ROCE
22%
18%
19%
22%
23%
23%
27%
27%
26%
31%
Fixed Asset Turnover
1.66
1.41
1.42
1.44
1.52
1.65
1.87
1.79
1.75
1.91
Receivable days
28
28
27
24
22
24
22
20
21
20
Inventory Days
51
54
50
47
46
45
43
47
51
47
Payable days
38
40
41
41
45
48
44
40
37
33
Cash Conversion Cycle
40
42
35
30
23
22
20
26
34
34
Total Debt/Equity
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.01
Interest Cover
95
167
173
180
167
113
71
124
123
123

News Update


  • FDC launches two variants of Favipiravir drug for Covid-19
    26th Aug 2020, 09:10 AM

    The company’s PiFLU and Favenza is currently available across the country.

    Read More
  • FDC inks pact to acquire additional stake in FDC SA
    8th Aug 2020, 08:53 AM

    The company would be holding 93% of the equity share capital of FOCSA, whereby FOC SA would become a subsidiary of the company

    Read More
  • FDC - Quarterly Results
    7th Aug 2020, 19:08 PM

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.